K. Ängeby

发表

Resistance to First-Line Anti-TB Drugs Is Associated with Reduced Nitric Oxide Susceptibility in Mycobacterium tuberculosis

A. Aseffa, T. Sundqvist, M. Lerm, 2012, PloS one.

Otomastoiditis caused by non-tuberculous mycobacteria: report of 16 cases, 3 with infection intracranially.

K. Ängeby, H. Edvardsson, L. Lundman, 2015, The Journal of laryngology and otology.

Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections

G. Kahlmeter, P. Juréen, S. Hoffner, 2010, Journal of Clinical Microbiology.

Intra- and Extracellular Activities of Trimethoprim-Sulfamethoxazole against Susceptible and Multidrug-Resistant Mycobacterium tuberculosis

J. Bruchfeld, P. Juréen, C. Giske, 2014, Antimicrobial Agents and Chemotherapy.

Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.

J. Paues, G. Kahlmeter, J. Bruchfeld, 2016, The Journal of antimicrobial chemotherapy.

Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis.

G. Kahlmeter, P. Juréen, S. Hoffner, 2012, Bulletin of the World Health Organization.

CD4+ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection.

P. Andersen, J. Bruchfeld, R. Szulkin, 2020, Tuberculosis.

A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic setting

Elena Hailu, A. Aseffa, L. Yamuah, 2014, BMC Research Notes.

The GenoType® MTBDRplus assay for detection of drug resistance in Mycobacterium tuberculosis in Sweden

E. Chryssanthou, K. Ängeby, 2012, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Tentative susceptibility testing breakpoint for the neuroleptic drug thioridazine, a treatment option for multi- and extensively drug resistant tuberculosis.

P. Juréen, E. Chryssanthou, T. Schön, 2012, International journal of mycobacteriology.

Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.

J. Bruchfeld, P. Juréen, C. Giske, 2015, International journal of mycobacteriology.

Meropenem-Clavulanic Acid Has High In Vitro Activity against Multidrug-Resistant Mycobacterium tuberculosis

J. Bruchfeld, P. Juréen, C. Giske, 2015, Antimicrobial Agents and Chemotherapy.

Rapid and Inexpensive Drug Susceptibility Testing of Mycobacterium tuberculosis with a Nitrate Reductase Assay

S. Hoffner, K. Ängeby, L. Klintz, 2002, Journal of Clinical Microbiology.

Antioxidants Protect Keratinocytes against M. ulcerans Mycolactone Cytotoxicity

M. Ståhle, P. Small, H. Akuffo, 2010, PloS one.

Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex

J. Parkhill, S. Niemann, T. Walker, 2020, Genome Medicine.

Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10.

Thomas Bo Schön, G. Kahlmeter, P. Juréen, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene Sequencing

Thomas Bo Schön, P. Juréen, S. Hoffner, 2011, Antimicrobial Agents and Chemotherapy.

Mycobacterium tuberculosis against pyrazinamide using wild-type MIC

Thomas Bo Schön, P. Juréen, S. Hoffner, 2011 .

A luciferase-based assay for rapid assessment of drug activity against Mycobacterium tuberculosis including monitoring of macrophage viability.

P. Juréen, M. Lerm, T. Schön, 2014, Journal of microbiological methods.

Drug Susceptibility Testing of Mycobacterium tuberculosis by a Nitrate Reductase Assay Applied Directly on Microscopy-Positive Sputum Samples

K. Ängeby, A. Souto, M. Ambroggi, 2005, Journal of Clinical Microbiology.

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data.

G. Kahlmeter, P. Juréen, S. Hoffner, 2010, The Journal of antimicrobial chemotherapy.

Should the 'bleach microscopy method' be recommended for improved case detection of tuberculosis? Literature review and key person analysis.

V. Diwan, S. Hoffner, K. Ängeby, 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.